Biphasic Lipid Vesicles for Transdermal Delivery of Large Molecules

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The barrier properties of the skin prevent most external substances from permeating into the body, and existing delivery systems for drugs, such as liposomes and solid lipid nanoparticles, are inefficient in delivering large molecules like proteins and nucleic acids through the skin.

Innovation Solution

A biphasic lipid vesicle composition comprising a lipid bilayer, an oil-in-water emulsion, and penetration enhancing agents like non-ionic surfactants with HLB of 10 or less, which are entrapped in the vesicles to enhance skin penetration of therapeutic compounds.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional delivery systems like liposomes and solid lipid nanoparticles are used, then the skin barrier properties are maintained, but the delivery efficiency of large molecules like proteins and nucleic acids is insufficient

Engineering Contradiction:
Improveskin barrier integrityVSAvoiddelivery efficiency of large molecules
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The patent modifies the physical and chemical parameters of the lipid vesicles by incorporating penetration enhancing agents with specific HLB values (3-10), adjusting the lipid composition ratios, and controlling vesicle size and charge characteristics to optimize both skin barrier compatibility and large molecule delivery efficiency

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention creates composite lipid vesicle systems by combining different types of lipids (phospholipids, cholesterol, fatty acids) with penetration enhancing agents and large molecule payloads, forming a multifunctional delivery system that simultaneously maintains barrier integrity and enhances permeation

Inventive Principle:
Principle #40Composite materials

2Productivity

If penetration enhancing agents are added to improve skin permeation, then the delivery of large molecules is enhanced, but the complexity of the formulation increases

Engineering Contradiction:
Improveskin permeation enhancementVSAvoidformulation complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The patent systematically evaluates and optimizes parameters including HLB value ranges (3-10), concentration levels, lipid composition ratios, and vesicle physical characteristics to achieve effective penetration enhancement while maintaining formulation simplicity and manufacturability

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The composition effectively delivers large molecules like peptides, proteins, and nucleic acids into the skin, improving topical delivery and treatment of skin conditions by enhancing the permeability of the skin barrier.

Implementation Method 1

one or more penetration enhancing agents entrapped in the lipid bilayer and/or the oil-in-water emulsion wherein the one or more penetration enhancing agents are one or more non-ionic surfactants having a hydrophilic-lipophilic balance (HLB) of 10 or less

Methodology Applied
Scientific EffectPermeation enhancement: Permeation

Implementation Method 2

an oil-in-water emulsion entrapped in the biphasic lipid vesicles, and stabilized by one or more surfactants

Methodology Applied
Scientific EffectSurfactant action: Surfactant

Data Source

PatentUS12544333B2Lipid vesicle compositions with penetration enhancing agents
Publication Date: 2026.02.10 DDS RES INC
  • US12544333B2 patent drawing
  • US12544333B2 patent drawing
  • US12544333B2 patent drawing

AI summary

The present application is related to a pharmaceutical composition a biphasic lipid vesicle comprising a lipid bilayer comprising vesicle forming lipids; an oil-in-water emulsion stabilized by one or more surfactants; one or more compounds; and one or more penetration enhancing agents. The one or more penetration enhancing agents include one or more non-ionic surfactants having a hydrophilic-lipophilic balance (HLB) of about 10 or less, alone or combination with one or more penetration enhancing agents selected from one or more of terpenes, alkaloids, salicylate derivatives, and polycationic surfactants and combinations thereof. The present application is also related to a pharmaceutical composition comprising a biphasic lipid vesicle comprising a lipid bilayer comprising vesicle forming lipids; an oil-in-water emulsion stabilized by one or more polycationic surfactants; and one or more compounds.